About
Company Profile
Management Team
Evolution
News
CDMO
Radiochemistry Services
Production of Radiopharmaceuticals
Pre-Clinical Studies
In Vitro Radioligand Receptor/Immuno-Binding Assays
Pharmacokinetics/Bio-distribution
Receptor Occupancy
Pharmacodynamics
Toxicity of Radiopharmaceuticals
Clinical Studies
Clinical Imaging Trials of Novel Drugs
Clinical Trials of Novel Radiopharmaceuticals
Medical Affairs
Biological Sample Analysis
Clinical Development Strategy
FIH Center
XingImaging
Radiopharmaceuticals R&D Service
One-stop Service for Radiopharmaceuticals
Radiochemistry Facility
Imaging and Animal Facility
Imaging Service
Imaging Analysis Service
Contact
Contact Us
Join Us
About MITRO
Exhibition | MITRO Invite You to Attend SNMMI2024 Annual Meeting
2024-04-30
The 2024 Annual Meeting of the American Society for Nuclear Medicine and Molecular Imaging (Society of Nuclear Medicine and Molecular Imaging, SNMMI) will be held June 8-11, 2024 in Toronto, Canada. The SNMMI annual meeting is recognized as the world's leading educational, scientific, research and social event in the field of nuclear medicine and molecular imaging. Every year, thousands of professionals in the field of nuclear medicine and molecular imaging from all over the world attend the meeting.
Annual Inspection of Jiangsu Province Laboratory Animal License
2024-03-20
Annual Inspection Report of Laboratory Animal License in Jiangsu Province
Radiopharmaceutical CRDMO MITRO Has Raised Nearly 400 Million Yuan to Support the Development of Innovative Drugs!
2024-03-18
On March 18, 2024, Yantai Dongcheng Pharmaceutical Group Co., Ltd. announced that it agreed to increase the capital and shares of its subsidiary MITRO (Yantai) Biotech Co., Ltd. (hereinafter referred to as "MITRO" or "the company"), which will be led by SDIC investment promotion, SDIC cohesion and Shandong local industrial fund, etc., with a total financing of nearly 400 million yuan.
Publicity on Declaring Postgraduate Workstation in Jiangsu Province in 2023
2023-06-30
According to the spirit of the documents issued by Jiangsu Provincial Education Department and Jiangsu Provincial Science and Technology Department "Notice on Doing a Good Job in Applying for Jiangsu Postgraduate Workstation and Jiangsu Provincial Outstanding Postgraduate Workstation Demonstration Base in 2023" (Su Jiaoban Letter [2023] No. 5) and "Administrative Measures for Jiangsu Postgraduate Workstation", the two sides decided to jointly apply for Jiangsu Postgraduate Workstation in 2023 through negotiation between the company and Nanjing Medical University School of Pharmacy.
MITRO Acquires Xing Imaging LLC to Strengthen Clinical Accompanying Diagnosis and Nuclear Drug Imaging Service Capabilities!
2022-12-12
On December 10, 2022, MITRO (Nanjing) Biotech Co., Ltd. announced that it would acquire Xing Imaging LLC, a nuclear drug conversion and clinical trial imaging CRO service company located in Delaware, USA, to assist international pharmaceutical companies in accurately diagnosing CRO services during clinical trials by using the preparation quality control technology of new PET drugs, PET scanning services and image reading management experience of new PET drugs.
Annual Inspection Report of Jiangsu Province Laboratory Animal License
2022-01-05
"Jiangsu Province Laboratory Animal License Annual Inspection Report" publicity